Exercise performance in vaccinated and unvaccinated individuals previously infected with SARS-CoV-2

By | January 4, 2022
A cross-sectional report from Israel demonstrated the protective effect of BNT162b2 mRNA vaccine (Pfizer–BioNTech) even after mild to moderate COVID-19).